Jan 09, 2026
212:211
For every 211 shares held, investors received 212. The price per share adjusted from $9.50 to $9.46.
The split itself did not change the total investment value.
Lytix Biopharma ASA (OSL:LYTIX) operates in the Pharmaceuticals: major industry.
Lytix Biopharma ASA company overviewLytix Biopharma ASA's most recent stock split was on January 9, 2026. It was a 212-for-211 forward split, so shareholders received 212 shares for every 211 they held.
Lytix Biopharma ASA has split its stock once. This history records one forward split, on January 9, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Lytix Biopharma ASA's 212-for-211 split on January 9, 2026, every 211 shares became 212 shares.
Lytix Biopharma ASA has not announced a new split in our records. Its most recent split was on January 9, 2026, less than a year ago. Companies announce splits in advance, and any new OSL:LYTIX split will appear on this page.
Already premium?